SEC 13F Intelligence

Mpm Bioimpact LLC / ORIC

Mpm Bioimpact LLC’s Oric Pharmaceuticals Inc Position

Does Mpm Bioimpact LLC own Oric Pharmaceuticals Inc (ORIC)? Yes — 1.80M shares worth $23M (+1.77% of its 13F portfolio) as of Q1 2026, up from 1.80M shares the prior filed quarter.

Position Value
$23M
Q1 2026
Shares
1.80M
% of Portfolio
+1.77%
Quarters Held
5
currently held

Position History ORIC

Reported value by quarter
Q1 ’25: $8MQ1 ’25Q2 ’25: $18MQ2 ’25Q3 ’25: $21MQ3 ’25Q4 ’25: $15MQ4 ’25Q1 ’26: $23MQ1 ’26filingsflow.com
QuarterSharesValue% of Portfolio
Q1 20261.80M$23M+1.77%
Q4 20251.80M$15M+1.68%
Q3 20251.73M$21M+3.40%
Q2 20251.73M$18M+3.04%
Q1 20251.40M$8M+1.34%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Mpm Bioimpact LLC’s full portfolio or all institutional holders of ORIC.